Statistics for Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer

Total visits

views
Editorial: FDA-Approved Drug Repositioning for P-Glycoprotein Overexpressing Resistant Cancer 0

Total visits per month

views
June 2024 0
July 2024 0
August 2024 0
September 2024 0
October 2024 0
November 2024 0
December 2024 0

File Visits

views
sungpil_fda_2021.pdf 45